Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial

Autor: Langenveld, J., Broekhuijsen, K., Baaren, G.J. van, Pampus, M.G. van, Kaam, A.H. van, Groen, H., Porath, M., Oudijk, M.A., Bloemenkamp, K.W., Groot, C.J. de, Beek, E. van, Huizen, M.E. van, Oosterbaan, H.P., Willekes, C., Wijnen-Duvekot, E.J., Franssen, M.T.M., Perquin, D.A.M., Sporken, J.M.J., Woiski, M.D., Bremer, H.A., Papatsonis, D.N.M., Brons, J.T.J., Kaplan, M., Bijvanck, B.W.A.N., Mol, B.W.J., HYPITAT-II Study Grp

Publikováno v: BMC Pregnancy and Childbirth, 11:50. BioMed Central
BMC Pregnancy and Childbirth, 11
BMC Pregnancy and Childbirth, 11:50. BMC
BMC Pregnancy and Childbirth
BMC Pregnancy and Childbirth, 11, pp. 50-50
BMC Pregnancy and Childbirth, 11, 50-50
BMC Pregnancy and Childbirth, Vol 11, Iss 1, p 50 (2011)
Langenveld, J, Broekhuijsen, K, van Baaren, G J, van Pampus, M G, van Kaam, A H, Groen, H, Porath, M, Oudijk, M A, Bloemenkamp, K W M, de Groot, C J M, van Beek, E, van Huizen, M E, Oosterbaan, H P, Willekes, C, Wijnen-Duvekot, E J, Franssen, M T, Perquin, D A, Sporken, J M, Woiski, M D, Bremer, H A, Papatsonis, D N M, Brons, J T, Kaplan, M, Bijvanck, B W & Mol, B W J 2011, ' Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial ', BMC Pregnancy and Childbirth, vol. 11, 50 . https://doi.org/10.1186/1471-2393-11-50
BMC Pregnancy and Childbirth, 11(1):50. BioMed Central
BMC pregnancy and childbirth, 11(1). BioMed Central

Background Gestational hypertension (GH) and pre-eclampsia (PE) can result in severe complications such as eclampsia, placental abruption, syndrome of Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) and ultimately even neonatal or materna

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26cf3fb87992260eb390be7cdf039da4
https://research.vumc.nl/en/publications/51a265fb-baa9-4b5f-ac09-17dfeabcc610

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II) : An open-label, randomised controlled trial

Autor: Broekhuijsen, K., Baaren, G.J. van, Pampus, M.G. van, Ganzevoort, W., Sikkema, J.M., Woiski, M.D., Oudijk, M.A., Bloemenkamp, K.W.M., Scheepers, H.C.J., Bremer, H.A., Rijnders, R.J.P., Loon, A.J. van, Perquin, D.A.M., Sporken, J.M.J., Papatsonis, D.N.M., Huizen, M.E. van, Vredevoogd, C.B., Brons, J.T.J., Kaplan, M., Kaam, A.H. van, Groen, H., Porath, M.M., Berg, P.P. van den, Mol, B.J., Franssen, M.T.M., Langenveld, J., HYPITAT-II Study Grp

Publikováno v: Obstetrical & Gynecological Survey, 70(10), 605-607. LIPPINCOTT WILLIAMS & WILKINS
Lancet, 385(9986), 2492-2501. Elsevier Limited
The Lancet, 385(9986), 2492. Elsevier Limited
Lancet, 385(9986), 2492-2501. Elsevier Science
Lancet, 385(9986), 2492-2501
The Lancet (London), 385, 2492-501
The Lancet (London), 385, 9986, pp. 2492-501
The Lancet, 385(9986), 2492-2501. ELSEVIER SCIENCE INC
Obstetrical & gynecological survey, 70(10), 605-607. Lippincott Williams and Wilkins

Patients with hypertensive disorders of pregnancy usually have the 2 treatment options, either immediate delivery or continuing the pregnancy. Although immediately delivery of the placenta is seen as the more definitive of the 2 treatments, it does c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374b96442ebd8b2a3fa15345ecb0a302
https://doi.org/10.1016/s0140-6736(14)61998-x

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.